We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Genomic Convergence Pinpoints Age-of Onset Gene

By Biotechdaily staff writers
Posted on 04 Nov 2003
Researchers have used a novel method called "genomic convergence” to identify a gene that plays an important role in the process that determines the age at which individuals begin to show symptoms of Alzheimer's and Parkinson's diseases.

Investigators at Duke University (Durham, NC, USA) had previously used genomic convergence to show genetic linkage of loci controlling age-at-onset in Alzheimer's disease (AD) and Parkinson's disease (PD) at a 15 cM region on chromosome 10q. More...
In the current study, which was published October 21, 2003, in the online edition of Human Molecular Genetics, they performed gene expression studies on hippocampus obtained from AD patients and controls that allowed them to eliminate all but four genes from linkage to age-at-onset. Further analysis of 1,773 AD patients and 635 PD patients revealed that of those four genes, only glutathione S-transferase, omega-1 (GSTO1) showed genetic differences associated with age-at-onset.

"By combining evidence based on gene expression and genetic association, we found a gene that modifies when the diseases start,” explained first author Dr. Yi-Ju Li, assistant research professor in medicine at Duke University. "Understanding the role this gene plays in Alzheimer's and Parkinson's diseases may, in the future, lead to a means to delay the disorders' onset.”




Related Links:
Duke University

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Manual Pipetting Aid
Pipette Controllers macro
New
Portable POCT Blood Gas Analyzer
BD100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.